Nephros to Present at the Virtual Summer Summit
SOUTH ORANGE, N.J., June 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that […]
Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement
– Combined Company Will Operate as Chinook Therapeutics and Advance Pipeline of Clinical-Stage Programs in Kidney Diseases, Led by Atrasentan […]
BMC Stock Holdings, Inc. To Present at Baird 2020 Virtual Global Consumer, Technology & Services Conference
RALEIGH, N.C., June 02, 2020 (GLOBE NEWSWIRE) — BMC Stock Holdings, Inc. (Nasdaq: BMCH) (“BMC” or the “Company”), one of […]
Gulfport Energy Corporation Announces Update to its 2020 Operational and Financial Guidance and Provides Update on Cost Saving Initiatives
OKLAHOMA CITY, June 02, 2020 (GLOBE NEWSWIRE) — Gulfport Energy Corporation (NASDAQ: GPOR) (“Gulfport” or the “Company”) today announced an […]
Akoustis Appoints New Vice President of Global Sales
– New Role Expands Executive Leadership with Experienced RF Professional –– Focus on Increasing Customer Engagements, Accelerating Revenue of Growing […]
GW Pharmaceuticals to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
LONDON and CARLSBAD, Calif., June 02, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the […]
Esports Entertainment Group Appoints Industry Veteran Magnus Leppäniemi as VP of Marketing and Head of Esports at Vie.gg
BIRKIRKARA, Malta, June 02, 2020 (GLOBE NEWSWIRE) — Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (or the “Company”), a licensed […]
Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., June 02, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company […]
LGI Homes Increases Presence in Raleigh Market
RALEIGH, N.C., June 02, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (Nasdaq:LGIH) is now selling in three new communities in […]
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
—TRV027 is a novel AT1 receptor selective agonist with the potential to treat acute lung injury and ARDSRobust clinical development […]
